C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma Article Swipe
Amrallah A. Mohammed
,
Hayam E. Rashed
,
Aziza E. Abdelrahman
,
Ahmed Obaya
,
Mostafa M. Toam
,
Hanim M Abdel Nour
,
Mohamed I. Abdelhamid
,
Fifi Mostafa Elsayed
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.31557/apjcp.2019.20.5.1463
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.31557/apjcp.2019.20.5.1463
Background: Due to lack of availability of gene expression profiling (GEP) for most developing countries and clinicians; the immunohistochemistry (IHC) is mostly used in the clinical application. The aim of our study is to check the possibility of using IHC to detect MYC and BCL2 in our patients with diffuse large B-cell lymphoma (DLBCL) instead of GEP to stratify them into high and low-risk groups. This will help in a proper treatment choice of subsequent improvement in the survival outcome. Method: During the study period, 90 DLBCL patients were eligible. MYC and BCL2 evaluated by IHC and gene rearrangement by real-time PCR (RT-PCR) and correlated with clinical-pathological features and survival. Results: Through IHC, the expression of MYC, BCL2, and double expression was detected in 35.6%, 46.7% and 30% of patients, respectively. While by RT-PCR, it was 4.53±0.74 for MYC compared with 2.18±0.78 for BCL-2. Most patients with BCL2+/MYC+; double-expressor and double-hit lymphomas (DEL and DHL) had high stage (III, IV), more extra-nodal involvement, (P value <0.001) and intermediate to high International Prognostic Index (IPI) risk profile (P-value <0.001). The median overall survival was 14 months and 6 months for DEL and DHL, respectively. While all patients with DHL died during the follow-up period, the median PFS were only 2 months for DEL. There was a statistically significant correlation between mRNA of MYC and BCL2 with their protein expression (p<0.001). Conclusion: Our results confirmed the unique characters and poor outcome associated with DEL and DHL mandated the need for more intense therapy and not the standard protocol. Moreover, the significant correlation between protein overexpression and gene rearrangement may open the door for the possibility to use IHC instead of RT-PCR in developing countries.
Related Topics
Concepts
Immunohistochemistry
Medicine
Lymphoma
Internal medicine
Diffuse large B-cell lymphoma
Chromosomal translocation
International Prognostic Index
Overall survival
Oncology
Gene expression profiling
Gene expression
Stage (stratigraphy)
Pathology
Gastroenterology
Gene
Biology
Paleontology
Biochemistry
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.31557/apjcp.2019.20.5.1463
- http://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdf
- OA Status
- gold
- Cited By
- 14
- References
- 34
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2945775664
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2945775664Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.31557/apjcp.2019.20.5.1463Digital Object Identifier
- Title
-
C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell LymphomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-05-01Full publication date if available
- Authors
-
Amrallah A. Mohammed, Hayam E. Rashed, Aziza E. Abdelrahman, Ahmed Obaya, Mostafa M. Toam, Hanim M Abdel Nour, Mohamed I. Abdelhamid, Fifi Mostafa ElsayedList of authors in order
- Landing page
-
https://doi.org/10.31557/apjcp.2019.20.5.1463Publisher landing page
- PDF URL
-
https://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdfDirect OA link when available
- Concepts
-
Immunohistochemistry, Medicine, Lymphoma, Internal medicine, Diffuse large B-cell lymphoma, Chromosomal translocation, International Prognostic Index, Overall survival, Oncology, Gene expression profiling, Gene expression, Stage (stratigraphy), Pathology, Gastroenterology, Gene, Biology, Paleontology, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
14Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 3, 2023: 2, 2022: 3, 2021: 2Per-year citation counts (last 5 years)
- References (count)
-
34Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2945775664 |
|---|---|
| doi | https://doi.org/10.31557/apjcp.2019.20.5.1463 |
| ids.doi | https://doi.org/10.31557/apjcp.2019.20.5.1463 |
| ids.mag | 2945775664 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31127909 |
| ids.openalex | https://openalex.org/W2945775664 |
| fwci | 1.14733416 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000368 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Aged |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000369 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Aged, 80 and over |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | Q000379 |
| mesh[5].descriptor_ui | D007150 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | methods |
| mesh[5].descriptor_name | Immunohistochemistry |
| mesh[6].qualifier_ui | Q000379 |
| mesh[6].descriptor_ui | D016130 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | methods |
| mesh[6].descriptor_name | Immunophenotyping |
| mesh[7].qualifier_ui | Q000235 |
| mesh[7].descriptor_ui | D016403 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | genetics |
| mesh[7].descriptor_name | Lymphoma, Large B-Cell, Diffuse |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008297 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Male |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008875 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Middle Aged |
| mesh[10].qualifier_ui | Q000235 |
| mesh[10].descriptor_ui | D019253 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | genetics |
| mesh[10].descriptor_name | Proto-Oncogene Proteins c-bcl-2 |
| mesh[11].qualifier_ui | Q000235 |
| mesh[11].descriptor_ui | D016271 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | genetics |
| mesh[11].descriptor_name | Proto-Oncogene Proteins c-myc |
| mesh[12].qualifier_ui | Q000235 |
| mesh[12].descriptor_ui | D012333 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | genetics |
| mesh[12].descriptor_name | RNA, Messenger |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D012189 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Retrospective Studies |
| mesh[14].qualifier_ui | Q000235 |
| mesh[14].descriptor_ui | D014178 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | genetics |
| mesh[14].descriptor_name | Translocation, Genetic |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000328 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Adult |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000368 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Aged |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000369 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Aged, 80 and over |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D005260 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Female |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000379 |
| mesh[20].descriptor_ui | D007150 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | methods |
| mesh[20].descriptor_name | Immunohistochemistry |
| mesh[21].qualifier_ui | Q000379 |
| mesh[21].descriptor_ui | D016130 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | methods |
| mesh[21].descriptor_name | Immunophenotyping |
| mesh[22].qualifier_ui | Q000235 |
| mesh[22].descriptor_ui | D016403 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | genetics |
| mesh[22].descriptor_name | Lymphoma, Large B-Cell, Diffuse |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D008297 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Male |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D008875 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Middle Aged |
| mesh[25].qualifier_ui | Q000235 |
| mesh[25].descriptor_ui | D019253 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | genetics |
| mesh[25].descriptor_name | Proto-Oncogene Proteins c-bcl-2 |
| mesh[26].qualifier_ui | Q000235 |
| mesh[26].descriptor_ui | D016271 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | genetics |
| mesh[26].descriptor_name | Proto-Oncogene Proteins c-myc |
| mesh[27].qualifier_ui | Q000235 |
| mesh[27].descriptor_ui | D012333 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | genetics |
| mesh[27].descriptor_name | RNA, Messenger |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D012189 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Retrospective Studies |
| mesh[29].qualifier_ui | Q000235 |
| mesh[29].descriptor_ui | D014178 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | genetics |
| mesh[29].descriptor_name | Translocation, Genetic |
| type | article |
| title | C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma |
| biblio.issue | 5 |
| biblio.volume | 20 |
| biblio.last_page | 1470 |
| biblio.first_page | 1463 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T12159 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9945999979972839 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | T-cell and Retrovirus Studies |
| topics[2].id | https://openalex.org/T11157 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9939000010490417 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2716 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Chronic Lymphocytic Leukemia Research |
| is_xpac | False |
| apc_list.value | 200 |
| apc_list.currency | USD |
| apc_list.value_usd | 200 |
| apc_paid.value | 200 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 200 |
| concepts[0].id | https://openalex.org/C204232928 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7711841464042664 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q899285 |
| concepts[0].display_name | Immunohistochemistry |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6550108790397644 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2779338263 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6418854594230652 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[2].display_name | Lymphoma |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6179848313331604 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2778559949 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5624651908874512 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2626074 |
| concepts[4].display_name | Diffuse large B-cell lymphoma |
| concepts[5].id | https://openalex.org/C138626823 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5577568411827087 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q916504 |
| concepts[5].display_name | Chromosomal translocation |
| concepts[6].id | https://openalex.org/C2778476033 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5479863882064819 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1667625 |
| concepts[6].display_name | International Prognostic Index |
| concepts[7].id | https://openalex.org/C3019894029 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5353330373764038 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q332823 |
| concepts[7].display_name | Overall survival |
| concepts[8].id | https://openalex.org/C143998085 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4560915529727936 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[8].display_name | Oncology |
| concepts[9].id | https://openalex.org/C18431079 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4379803240299225 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1502169 |
| concepts[9].display_name | Gene expression profiling |
| concepts[10].id | https://openalex.org/C150194340 |
| concepts[10].level | 3 |
| concepts[10].score | 0.42960041761398315 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[10].display_name | Gene expression |
| concepts[11].id | https://openalex.org/C146357865 |
| concepts[11].level | 2 |
| concepts[11].score | 0.41713351011276245 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[11].display_name | Stage (stratigraphy) |
| concepts[12].id | https://openalex.org/C142724271 |
| concepts[12].level | 1 |
| concepts[12].score | 0.4060029089450836 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[12].display_name | Pathology |
| concepts[13].id | https://openalex.org/C90924648 |
| concepts[13].level | 1 |
| concepts[13].score | 0.37362784147262573 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[13].display_name | Gastroenterology |
| concepts[14].id | https://openalex.org/C104317684 |
| concepts[14].level | 2 |
| concepts[14].score | 0.3619316816329956 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[14].display_name | Gene |
| concepts[15].id | https://openalex.org/C86803240 |
| concepts[15].level | 0 |
| concepts[15].score | 0.24486613273620605 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[15].display_name | Biology |
| concepts[16].id | https://openalex.org/C151730666 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[16].display_name | Paleontology |
| concepts[17].id | https://openalex.org/C55493867 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[17].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/immunohistochemistry |
| keywords[0].score | 0.7711841464042664 |
| keywords[0].display_name | Immunohistochemistry |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6550108790397644 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/lymphoma |
| keywords[2].score | 0.6418854594230652 |
| keywords[2].display_name | Lymphoma |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6179848313331604 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/diffuse-large-b-cell-lymphoma |
| keywords[4].score | 0.5624651908874512 |
| keywords[4].display_name | Diffuse large B-cell lymphoma |
| keywords[5].id | https://openalex.org/keywords/chromosomal-translocation |
| keywords[5].score | 0.5577568411827087 |
| keywords[5].display_name | Chromosomal translocation |
| keywords[6].id | https://openalex.org/keywords/international-prognostic-index |
| keywords[6].score | 0.5479863882064819 |
| keywords[6].display_name | International Prognostic Index |
| keywords[7].id | https://openalex.org/keywords/overall-survival |
| keywords[7].score | 0.5353330373764038 |
| keywords[7].display_name | Overall survival |
| keywords[8].id | https://openalex.org/keywords/oncology |
| keywords[8].score | 0.4560915529727936 |
| keywords[8].display_name | Oncology |
| keywords[9].id | https://openalex.org/keywords/gene-expression-profiling |
| keywords[9].score | 0.4379803240299225 |
| keywords[9].display_name | Gene expression profiling |
| keywords[10].id | https://openalex.org/keywords/gene-expression |
| keywords[10].score | 0.42960041761398315 |
| keywords[10].display_name | Gene expression |
| keywords[11].id | https://openalex.org/keywords/stage |
| keywords[11].score | 0.41713351011276245 |
| keywords[11].display_name | Stage (stratigraphy) |
| keywords[12].id | https://openalex.org/keywords/pathology |
| keywords[12].score | 0.4060029089450836 |
| keywords[12].display_name | Pathology |
| keywords[13].id | https://openalex.org/keywords/gastroenterology |
| keywords[13].score | 0.37362784147262573 |
| keywords[13].display_name | Gastroenterology |
| keywords[14].id | https://openalex.org/keywords/gene |
| keywords[14].score | 0.3619316816329956 |
| keywords[14].display_name | Gene |
| keywords[15].id | https://openalex.org/keywords/biology |
| keywords[15].score | 0.24486613273620605 |
| keywords[15].display_name | Biology |
| language | en |
| locations[0].id | doi:10.31557/apjcp.2019.20.5.1463 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S121579133 |
| locations[0].source.issn | 1513-7368, 2476-762X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1513-7368 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Asian Pacific Journal of Cancer Prevention |
| locations[0].source.host_organization | https://openalex.org/P4310319060 |
| locations[0].source.host_organization_name | West Asia Organization for Cancer Prevention |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319060 |
| locations[0].source.host_organization_lineage_names | West Asia Organization for Cancer Prevention |
| locations[0].license | cc-by |
| locations[0].pdf_url | http://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Asian Pacific Journal of Cancer Prevention |
| locations[0].landing_page_url | https://doi.org/10.31557/apjcp.2019.20.5.1463 |
| locations[1].id | pmid:31127909 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Asian Pacific journal of cancer prevention : APJCP |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31127909 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:6857872 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Asian Pac J Cancer Prev |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6857872 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5083671561 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4582-5420 |
| authorships[0].author.display_name | Amrallah A. Mohammed |
| authorships[0].countries | EG |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[0].institutions[0].id | https://openalex.org/I192398990 |
| authorships[0].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[0].institutions[0].country_code | EG |
| authorships[0].institutions[0].display_name | Zagazig University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Amrallah A Mohammed |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medical Oncology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[1].author.id | https://openalex.org/A5050596095 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8204-9937 |
| authorships[1].author.display_name | Hayam E. Rashed |
| authorships[1].countries | EG |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pathology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[1].institutions[0].id | https://openalex.org/I192398990 |
| authorships[1].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[1].institutions[0].country_code | EG |
| authorships[1].institutions[0].display_name | Zagazig University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hayam E Rashed |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pathology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[2].author.id | https://openalex.org/A5057460569 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4074-4779 |
| authorships[2].author.display_name | Aziza E. Abdelrahman |
| authorships[2].countries | EG |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pathology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[2].institutions[0].id | https://openalex.org/I192398990 |
| authorships[2].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[2].institutions[0].country_code | EG |
| authorships[2].institutions[0].display_name | Zagazig University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Aziza E Abdelrahman |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pathology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[3].author.id | https://openalex.org/A5012487818 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Ahmed Obaya |
| authorships[3].countries | EG |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Clinical Oncology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[3].institutions[0].id | https://openalex.org/I192398990 |
| authorships[3].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[3].institutions[0].country_code | EG |
| authorships[3].institutions[0].display_name | Zagazig University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ahmed A Obaya |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Clinical Oncology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[4].author.id | https://openalex.org/A5005967311 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7979-0791 |
| authorships[4].author.display_name | Mostafa M. Toam |
| authorships[4].countries | EG |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Clinical Oncology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[4].institutions[0].id | https://openalex.org/I192398990 |
| authorships[4].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[4].institutions[0].country_code | EG |
| authorships[4].institutions[0].display_name | Zagazig University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mostafa Toam |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Clinical Oncology, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[5].author.id | https://openalex.org/A5027747119 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Hanim M Abdel Nour |
| authorships[5].countries | EG |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Biochemistry, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[5].institutions[0].id | https://openalex.org/I192398990 |
| authorships[5].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[5].institutions[0].country_code | EG |
| authorships[5].institutions[0].display_name | Zagazig University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Hanim M Abdel Nour |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Biochemistry, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[6].author.id | https://openalex.org/A5040846085 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1296-5435 |
| authorships[6].author.display_name | Mohamed I. Abdelhamid |
| authorships[6].countries | EG |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I192398990 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of General Surgery, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[6].institutions[0].id | https://openalex.org/I192398990 |
| authorships[6].institutions[0].ror | https://ror.org/053g6we49 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I192398990 |
| authorships[6].institutions[0].country_code | EG |
| authorships[6].institutions[0].display_name | Zagazig University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mohamed I Abdelhamid |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of General Surgery, Faculty of Medicine, Zagazig University, Egypt. |
| authorships[7].author.id | https://openalex.org/A5046749687 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Fifi Mostafa Elsayed |
| authorships[7].countries | EG |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I114794399 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Suez Canal University, Egypt. |
| authorships[7].institutions[0].id | https://openalex.org/I114794399 |
| authorships[7].institutions[0].ror | https://ror.org/02m82p074 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I114794399 |
| authorships[7].institutions[0].country_code | EG |
| authorships[7].institutions[0].display_name | Suez Canal University |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Fifi Mostafa Elsayed |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Suez Canal University, Egypt. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2381735876, https://openalex.org/W2021173905, https://openalex.org/W3088167459, https://openalex.org/W2060050787, https://openalex.org/W2390523857, https://openalex.org/W4232815876, https://openalex.org/W2115179216, https://openalex.org/W3023665323, https://openalex.org/W2980891769, https://openalex.org/W2341926683 |
| cited_by_count | 14 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 3 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 2 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.31557/apjcp.2019.20.5.1463 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S121579133 |
| best_oa_location.source.issn | 1513-7368, 2476-762X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1513-7368 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Asian Pacific Journal of Cancer Prevention |
| best_oa_location.source.host_organization | https://openalex.org/P4310319060 |
| best_oa_location.source.host_organization_name | West Asia Organization for Cancer Prevention |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319060 |
| best_oa_location.source.host_organization_lineage_names | West Asia Organization for Cancer Prevention |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | http://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Asian Pacific Journal of Cancer Prevention |
| best_oa_location.landing_page_url | https://doi.org/10.31557/apjcp.2019.20.5.1463 |
| primary_location.id | doi:10.31557/apjcp.2019.20.5.1463 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S121579133 |
| primary_location.source.issn | 1513-7368, 2476-762X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1513-7368 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Asian Pacific Journal of Cancer Prevention |
| primary_location.source.host_organization | https://openalex.org/P4310319060 |
| primary_location.source.host_organization_name | West Asia Organization for Cancer Prevention |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319060 |
| primary_location.source.host_organization_lineage_names | West Asia Organization for Cancer Prevention |
| primary_location.license | cc-by |
| primary_location.pdf_url | http://journal.waocp.org/article_87870_09b8cf89526f0321d498a48002600378.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Asian Pacific Journal of Cancer Prevention |
| primary_location.landing_page_url | https://doi.org/10.31557/apjcp.2019.20.5.1463 |
| publication_date | 2019-05-01 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2588300199, https://openalex.org/W6666592293, https://openalex.org/W2033271012, https://openalex.org/W6673196653, https://openalex.org/W2120415962, https://openalex.org/W2056641238, https://openalex.org/W2148752139, https://openalex.org/W2077482922, https://openalex.org/W6642915726, https://openalex.org/W1534564046, https://openalex.org/W1542384754, https://openalex.org/W2570839783, https://openalex.org/W2783762936, https://openalex.org/W2894196895, https://openalex.org/W2057239580, https://openalex.org/W2145304413, https://openalex.org/W2153422981, https://openalex.org/W2310716991, https://openalex.org/W2735133456, https://openalex.org/W2884096807, https://openalex.org/W2057456224, https://openalex.org/W2029192827, https://openalex.org/W2037796411, https://openalex.org/W2064223130, https://openalex.org/W2107277218, https://openalex.org/W1964184380, https://openalex.org/W2331933097, https://openalex.org/W2091130540, https://openalex.org/W1969998568, https://openalex.org/W4385986623, https://openalex.org/W2072646319, https://openalex.org/W4243182105, https://openalex.org/W2137216850, https://openalex.org/W2624307079 |
| referenced_works_count | 34 |
| abstract_inverted_index.2 | 208 |
| abstract_inverted_index.6 | 186 |
| abstract_inverted_index.a | 69, 214 |
| abstract_inverted_index.(P | 163 |
| abstract_inverted_index.14 | 183 |
| abstract_inverted_index.90 | 85 |
| abstract_inverted_index.by | 94, 99, 132 |
| abstract_inverted_index.in | 23, 45, 68, 76, 123, 279 |
| abstract_inverted_index.is | 20, 32 |
| abstract_inverted_index.it | 134 |
| abstract_inverted_index.of | 4, 6, 29, 37, 55, 73, 115, 128, 220, 277 |
| abstract_inverted_index.to | 2, 33, 40, 57, 168, 273 |
| abstract_inverted_index.30% | 127 |
| abstract_inverted_index.DEL | 189, 241 |
| abstract_inverted_index.DHL | 197, 243 |
| abstract_inverted_index.Due | 1 |
| abstract_inverted_index.GEP | 56 |
| abstract_inverted_index.IHC | 39, 95, 275 |
| abstract_inverted_index.MYC | 42, 90, 138, 221 |
| abstract_inverted_index.Our | 230 |
| abstract_inverted_index.PCR | 101 |
| abstract_inverted_index.PFS | 205 |
| abstract_inverted_index.The | 27, 178 |
| abstract_inverted_index.aim | 28 |
| abstract_inverted_index.all | 194 |
| abstract_inverted_index.and | 15, 43, 62, 91, 96, 103, 108, 118, 126, 149, 153, 166, 185, 190, 222, 236, 242, 251, 263 |
| abstract_inverted_index.for | 11, 137, 142, 188, 210, 247, 270 |
| abstract_inverted_index.had | 155 |
| abstract_inverted_index.may | 266 |
| abstract_inverted_index.not | 252 |
| abstract_inverted_index.our | 30, 46 |
| abstract_inverted_index.the | 17, 24, 35, 77, 82, 113, 200, 203, 233, 245, 253, 257, 268, 271 |
| abstract_inverted_index.use | 274 |
| abstract_inverted_index.was | 121, 135, 182, 213 |
| abstract_inverted_index.(DEL | 152 |
| abstract_inverted_index.BCL2 | 44, 92, 223 |
| abstract_inverted_index.DEL. | 211 |
| abstract_inverted_index.DHL) | 154 |
| abstract_inverted_index.DHL, | 191 |
| abstract_inverted_index.IHC, | 112 |
| abstract_inverted_index.IV), | 159 |
| abstract_inverted_index.MYC, | 116 |
| abstract_inverted_index.Most | 144 |
| abstract_inverted_index.This | 65 |
| abstract_inverted_index.died | 198 |
| abstract_inverted_index.door | 269 |
| abstract_inverted_index.gene | 7, 97, 264 |
| abstract_inverted_index.help | 67 |
| abstract_inverted_index.high | 61, 156, 169 |
| abstract_inverted_index.into | 60 |
| abstract_inverted_index.lack | 3 |
| abstract_inverted_index.mRNA | 219 |
| abstract_inverted_index.more | 160, 248 |
| abstract_inverted_index.most | 12 |
| abstract_inverted_index.need | 246 |
| abstract_inverted_index.only | 207 |
| abstract_inverted_index.open | 267 |
| abstract_inverted_index.poor | 237 |
| abstract_inverted_index.risk | 174 |
| abstract_inverted_index.them | 59 |
| abstract_inverted_index.used | 22 |
| abstract_inverted_index.were | 88, 206 |
| abstract_inverted_index.will | 66 |
| abstract_inverted_index.with | 48, 105, 140, 146, 196, 224, 240 |
| abstract_inverted_index.(GEP) | 10 |
| abstract_inverted_index.(IHC) | 19 |
| abstract_inverted_index.(III, | 158 |
| abstract_inverted_index.(IPI) | 173 |
| abstract_inverted_index.46.7% | 125 |
| abstract_inverted_index.BCL2, | 117 |
| abstract_inverted_index.DLBCL | 86 |
| abstract_inverted_index.Index | 172 |
| abstract_inverted_index.There | 212 |
| abstract_inverted_index.While | 131, 193 |
| abstract_inverted_index.check | 34 |
| abstract_inverted_index.large | 50 |
| abstract_inverted_index.stage | 157 |
| abstract_inverted_index.study | 31, 83 |
| abstract_inverted_index.their | 225 |
| abstract_inverted_index.using | 38 |
| abstract_inverted_index.value | 164 |
| abstract_inverted_index.35.6%, | 124 |
| abstract_inverted_index.B-cell | 51 |
| abstract_inverted_index.BCL-2. | 143 |
| abstract_inverted_index.During | 81 |
| abstract_inverted_index.RT-PCR | 278 |
| abstract_inverted_index.choice | 72 |
| abstract_inverted_index.detect | 41 |
| abstract_inverted_index.double | 119 |
| abstract_inverted_index.during | 199 |
| abstract_inverted_index.median | 179, 204 |
| abstract_inverted_index.months | 184, 187, 209 |
| abstract_inverted_index.mostly | 21 |
| abstract_inverted_index.proper | 70 |
| abstract_inverted_index.unique | 234 |
| abstract_inverted_index.(DLBCL) | 53 |
| abstract_inverted_index.<0.001) | 165 |
| abstract_inverted_index.Method: | 80 |
| abstract_inverted_index.RT-PCR, | 133 |
| abstract_inverted_index.Through | 111 |
| abstract_inverted_index.between | 218, 260 |
| abstract_inverted_index.diffuse | 49 |
| abstract_inverted_index.groups. | 64 |
| abstract_inverted_index.instead | 54, 276 |
| abstract_inverted_index.intense | 249 |
| abstract_inverted_index.outcome | 238 |
| abstract_inverted_index.overall | 180 |
| abstract_inverted_index.period, | 84, 202 |
| abstract_inverted_index.profile | 175 |
| abstract_inverted_index.protein | 226, 261 |
| abstract_inverted_index.results | 231 |
| abstract_inverted_index.therapy | 250 |
| abstract_inverted_index.(P-value | 176 |
| abstract_inverted_index.(RT-PCR) | 102 |
| abstract_inverted_index.<0.001). | 177 |
| abstract_inverted_index.Results: | 110 |
| abstract_inverted_index.clinical | 25 |
| abstract_inverted_index.compared | 139 |
| abstract_inverted_index.detected | 122 |
| abstract_inverted_index.features | 107 |
| abstract_inverted_index.low-risk | 63 |
| abstract_inverted_index.lymphoma | 52 |
| abstract_inverted_index.mandated | 244 |
| abstract_inverted_index.outcome. | 79 |
| abstract_inverted_index.patients | 47, 87, 145, 195 |
| abstract_inverted_index.standard | 254 |
| abstract_inverted_index.stratify | 58 |
| abstract_inverted_index.survival | 78, 181 |
| abstract_inverted_index.Moreover, | 256 |
| abstract_inverted_index.confirmed | 232 |
| abstract_inverted_index.countries | 14 |
| abstract_inverted_index.eligible. | 89 |
| abstract_inverted_index.evaluated | 93 |
| abstract_inverted_index.follow-up | 201 |
| abstract_inverted_index.lymphomas | 151 |
| abstract_inverted_index.patients, | 129 |
| abstract_inverted_index.profiling | 9 |
| abstract_inverted_index.protocol. | 255 |
| abstract_inverted_index.real-time | 100 |
| abstract_inverted_index.survival. | 109 |
| abstract_inverted_index.treatment | 71 |
| abstract_inverted_index.(p<0.001). | 228 |
| abstract_inverted_index.2.18±0.78 | 141 |
| abstract_inverted_index.4.53±0.74 | 136 |
| abstract_inverted_index.Prognostic | 171 |
| abstract_inverted_index.associated | 239 |
| abstract_inverted_index.characters | 235 |
| abstract_inverted_index.correlated | 104 |
| abstract_inverted_index.countries. | 281 |
| abstract_inverted_index.developing | 13, 280 |
| abstract_inverted_index.double-hit | 150 |
| abstract_inverted_index.expression | 8, 114, 120, 227 |
| abstract_inverted_index.subsequent | 74 |
| abstract_inverted_index.BCL2+/MYC+; | 147 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Conclusion: | 229 |
| abstract_inverted_index.clinicians; | 16 |
| abstract_inverted_index.correlation | 217, 259 |
| abstract_inverted_index.extra-nodal | 161 |
| abstract_inverted_index.improvement | 75 |
| abstract_inverted_index.possibility | 36, 272 |
| abstract_inverted_index.significant | 216, 258 |
| abstract_inverted_index.application. | 26 |
| abstract_inverted_index.availability | 5 |
| abstract_inverted_index.intermediate | 167 |
| abstract_inverted_index.involvement, | 162 |
| abstract_inverted_index.International | 170 |
| abstract_inverted_index.rearrangement | 98, 265 |
| abstract_inverted_index.respectively. | 130, 192 |
| abstract_inverted_index.statistically | 215 |
| abstract_inverted_index.overexpression | 262 |
| abstract_inverted_index.double-expressor | 148 |
| abstract_inverted_index.immunohistochemistry | 18 |
| abstract_inverted_index.clinical-pathological | 106 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/17 |
| sustainable_development_goals[0].score | 0.5400000214576721 |
| sustainable_development_goals[0].display_name | Partnerships for the goals |
| citation_normalized_percentile.value | 0.73873007 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |